G

GPCR

Structure Therapeutics Inc.
HealthcareBiotechnology|NASDAQ Global Market|US

Price

$53.48

Market Cap

$3.08B

Beta

-1.90

P/E

0.0

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%
EPS Growth (YoY)-2.56%
Revenue CAGR 3Y+0.00%
P/E Ratio0.0
PEG Ratio
FCF Yield-7.33%
Debt / Equity0.00
Interest Coverage999.0x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for GPCR.

GPCR — Structure Therapeutics Inc. Stock Analysis | Tessera Alpha